Table I.
Classification of patients by gene(s) tested.
| KAL1 Kit | KAL2 Kit | KAL1&KAL2 Kits | Total Patients Studied | ||||
|---|---|---|---|---|---|---|---|
| All subjects studied n = 54 | All subjects studied n = 100 | Studied with both kits n = 42 | Individual subjects n = 112 (154–42) | ||||
| Male | 45 | Male | 72 | Male | 38 | Male | 79 |
| Anosmic/Hypos | 33 | Anosmic/Hypos | 37 | Anosmic/Hypos | 26 | Anosmic/Hypos | 44 |
| Normosmic | 12 | Normosmic | 18 | Normosmic | 12 | Normosmic | 18 |
| Unknown | 0 | Unknown | 17 | Unknown | 0 | Unknown | 17 |
| Complete IHH | 13 | Complete IHH | 15 | Complete IHH | 10 | Complete IHH | 18 |
| Incomplete IHH | 20 | Incomplete IHH | 19 | Incomplete IHH | 18 | Incomplete IHH | 21 |
| Unknown | 12 | Unknown | 38 | Unknown | 10 | Unknown | 40 |
| Female | 9 | Female | 28 | Female | 4 | Female | 33 |
| Anosmic/Hypos | 7 | Anosmic/Hypos | 7 | Anosmic/Hypos | 3 | Anosmic/Hypos | 11 |
| Normosmic | 2 | Normosmic | 10 | Normosmic | 1 | Normosmic | 11 |
| Unknown | 0 | Unknown | 11 | Unknown | 0 | Unknown | 11 |
| Complete IHH | 3 | Complete IHH | 7 | Complete IHH | 2 | Complete IHH | 8 |
| Incomplete IHH | 2 | Incomplete IHH | 6 | Incomplete IHH | 0 | Incomplete IHH | 8 |
| Unknown | 4 | Unknown | 15 | Unknown | 2 | Unknown | 17 |
| Totals | 54 | Totals | 100 | Totals | 42 | Totals | 112 |
| Anosmic/Hypos | 40 | Anosmic/Hypos | 44 | Anosmic/Hypos | 29 | Anosmic/Hypos | 55 |
| Normosmic | 14 | Normosmic | 28 | Normosmic | 13 | Normosmic | 29 |
| Unknown | 0 | Unknown | 28 | Unknown | 0 | Unknown | 28 |
| Complete IHH | 16 | Complete IHH | 22 | Complete IHH | 12 | Complete IHH | 26 |
| Incomplete IHH | 22 | Incomplete IHH | 25 | Incomplete IHH | 18 | Incomplete IHH | 29 |
| Unknown | 16 | Unknown | 53 | Unknown | 12 | Unknown | 57 |